9:22 AM
Leo Group India
| ||
| Takeda Pharma to acquire Brazilian-based Multilab for BRL 500 million pharmabiz.com Takeda Pharmaceutical Company Limited, a research-based global company, and Multilab Indústria e Comércio de Produtos Farmacêuticos Ltda. (Multilab), a leading Brazilian pharmaceutical company, jointly announced that both parties have signed an ... See all stories on this topic » | ||
| KV Pharmaceutical Company States That Its Policy is Not to Comment on Unusual ... MarketWatch (press release) LOUIS, May 25, 2012 /PRNewswire via COMTEX/ -- KV Pharmaceutical Company (the "Company") today announced that in view of the unusual market activity in the Company's common stock, the NYSE has contacted the Company in accordance with its usual practice ... See all stories on this topic » | ||
| Takeda Pharmaceutical Widens Global Footprint With $250M Multilab Acquisition BioWorld Online By Jennifer Boggs Only weeks after disclosing its goal of expanding into emerging markets in its 2012-2014 Mid-Range Plan, Takeda Pharmaceutical Co. Ltd. made a move in Brazil with the acquisition of Multilab Industria e Comercio de Produtos ... See all stories on this topic » | ||
| Watson confirms Testim patent challenge pharmabiz.com Watson Laboratories, Inc., a subsidiary of Watson Pharmaceuticals, Inc., has filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration (FDA) seeking approval to market testosterone gel, 1%. Watson's 1% testosterone gel ... See all stories on this topic » | ||
| SOCMA's Bulk Pharmaceuticals Task Force Hails Senate Passage of FDA User Fee Bill Sacramento Bee By Society of Chemical Manufacturers and Affiliates WASHINGTON, May 25, 2012 /PRNewswire-USNewswire/ -- The Bulk Pharmaceuticals Task Force (BPTF), an affiliate of the Society of Chemical Manufacturers and Affiliates (SOCMA), today commended the Senate ... See all stories on this topic » | ||
| Cannabis Science Gets Set to Release "Phytiva" Its Newest Brand of Over-the ... MarketWatch (press release) COLORADO SPRINGS, Colo., May 25, 2012 (BUSINESS WIRE) -- Cannabis Science, Inc. (OBB:CBIS) , a pioneering US biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to provide insight on the upcoming release of its' new ... See all stories on this topic » | ||
| Biology offers new options Times of India With new options in the pharmaceutical, food processing and agricultural industries, academics is no longer the only way forward for biological science graduates. "Biomedical engineering, bioinformatics, biometrics, biochemistry, microbiology, ... See all stories on this topic » | ||
| Plant Bioscience grants Alnylam world-wide license to Baulcombe patent pharmabiz.com Leading RNAi therapeutics company, Alnylam Pharmaceuticals, Inc. and Plant Bioscience Limited (PBL), a technology development and intellectual property (IP) management company, have entered into a licensing agreement. PBL has granted Alnylam a ... See all stories on this topic » | ||
| Mylan settles patent litigation relating to Sunovion's Brovana product pharmabiz.com Mylan Inc., a global pharmaceutical company committed to setting new standards in healthcare, announced that Mylan Specialty LP, f/k/a Dey Pharma, LP, has entered into an agreement with Sunovion Pharmaceuticals Inc., f/k/a Sepracor Inc., to resolve the ... See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment